Atorvastatin as a potential anti-malarial drug: in vitro synergy in combinational therapy with quinine against <it>Plasmodium falciparum</it>
<p>Abstract</p> <p>Background</p> <p>Quinine (QN) remains the first line anti-malarial drug for the treatment of complicated malaria in Europe and Africa. The emergence of QN resistance has been documented. QN resistance is not yet a significant problem, but there is an...
Main Authors: | Pradines Bruno, Rogier Christophe, Amalvict Rémy, Baret Eric, Gil Marine, Briolant Sébastien, Dormoi Jerome, Wurtz Nathalie, Henry Maud, Parquet Véronique |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-05-01
|
Series: | Malaria Journal |
Online Access: | http://www.malariajournal.com/content/9/1/139 |
Similar Items
-
<it>In vitro </it>susceptibility to quinine and microsatellite variations of the <it>Plasmodium falciparum </it>Na<sup>+</sup>/H<sup>+ </sup>exchanger (<it>Pfnhe-1) </it>gene: the absence of association in clinical isolates from the Republic of Congo
by: Rogier Christophe, et al.
Published: (2011-02-01) -
Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro <it>Plasmodium falciparum </it>susceptibility to standard anti-malarial drugs
by: Travers Dominique, et al.
Published: (2011-01-01) -
Plasmodium falciparum with Multidrug Resistance 1 Gene Duplications, Senegal
by: Aurélie Pascual, et al.
Published: (2013-05-01) -
Methylene Blue-Based Combination Therapy with Amodiaquine Prevents Severe Malaria in an Experimental Rodent Model
by: Jérôme Dormoi, et al.
Published: (2022-09-01) -
Prevalence of molecular markers of <it>Plasmodium falciparum</it> drug resistance in Dakar, Senegal
by: Wurtz Nathalie, et al.
Published: (2012-06-01)